Sjögren’s syndrome gene therapy (Ibex)

N/A

Report date: 2025/03/20 15:55:18

Base Information

Drug NameSjögren’s syndrome gene therapy (Ibex)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIbex Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesIbex Biosciences LLC
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A